STOCK TITAN

[Form 4] Orthofix Medical Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Orthofix Medical (NASDAQ:OFIX) filed a Form 4 disclosing that director Vickie L. Capps was granted 18,841 deferred stock units on 18 June 2025. These units vest in full one year after the grant date, contingent upon continued board service, and will convert into common shares within 45 days of her separation from the company. Following the award, Capps’ reported beneficial ownership increased to 21,934 shares, which includes 3,093 previously disclosed units. The award carries no purchase price and no insider sales were reported.

Orthofix Medical (NASDAQ:OFIX) ha presentato un Modulo 4 comunicando che la direttrice Vickie L. Capps ha ricevuto 18.841 unità azionarie differite il 18 giugno 2025. Queste unità maturano completamente un anno dopo la data di assegnazione, a condizione che prosegua il servizio nel consiglio, e si convertiranno in azioni ordinarie entro 45 giorni dalla sua separazione dall’azienda. Dopo l’assegnazione, la proprietà beneficiaria di Capps è aumentata a 21.934 azioni, incluse 3.093 unità precedentemente comunicate. L’assegnazione non prevede alcun prezzo d’acquisto e non sono state segnalate vendite da parte degli insider.

Orthofix Medical (NASDAQ:OFIX) presentó un Formulario 4 revelando que la directora Vickie L. Capps recibió 18,841 unidades de acciones diferidas el 18 de junio de 2025. Estas unidades se consolidan en su totalidad un año después de la fecha de concesión, condicionado a la continuidad en el consejo, y se convertirán en acciones comunes dentro de los 45 días posteriores a su separación de la empresa. Tras la adjudicación, la propiedad beneficiaria reportada de Capps aumentó a 21,934 acciones, que incluyen 3,093 unidades previamente divulgadas. La adjudicación no tiene precio de compra y no se reportaron ventas internas.

Orthofix Medical (NASDAQ:OFIX)는 이사 Vickie L. Capps가 2025년 6월 18일에 18,841개의 이연 주식 단위를 부여받았음을 공개하는 Form 4를 제출했습니다. 이 단위들은 부여일로부터 1년 후에 전액 취득되며, 계속 이사회에 재직하는 조건이 붙어 있습니다. 또한, 회사와의 분리 후 45일 이내에 보통주로 전환됩니다. 이번 수여로 인해 Capps의 보고된 실질 소유 주식 수는 21,934주로 증가했으며, 여기에는 이전에 공개된 3,093 단위가 포함되어 있습니다. 이번 수여는 구매 가격이 없으며, 내부자 매도는 보고되지 않았습니다.

Orthofix Medical (NASDAQ:OFIX) a déposé un formulaire 4 révélant que la directrice Vickie L. Capps s’est vu attribuer 18 841 unités d’actions différées le 18 juin 2025. Ces unités seront entièrement acquises un an après la date d’attribution, sous réserve de la poursuite de son mandat au conseil, et seront converties en actions ordinaires dans les 45 jours suivant son départ de l’entreprise. Suite à cette attribution, la propriété bénéficiaire déclarée de Capps est passée à 21 934 actions, incluant 3 093 unités déjà divulguées auparavant. Cette attribution ne comporte aucun prix d’achat et aucune vente d’initiés n’a été signalée.

Orthofix Medical (NASDAQ:OFIX) hat ein Formular 4 eingereicht, in dem offengelegt wird, dass die Direktorin Vickie L. Capps am 18. Juni 2025 18.841 aufgeschobene Aktienanteile erhalten hat. Diese Anteile werden ein Jahr nach dem Gewährungsdatum vollständig erworben, vorausgesetzt, sie bleibt im Vorstand tätig, und werden innerhalb von 45 Tagen nach ihrem Ausscheiden aus dem Unternehmen in Stammaktien umgewandelt. Nach der Zuteilung erhöhte sich Capps’ gemeldetes wirtschaftliches Eigentum auf 21.934 Aktien, einschließlich 3.093 zuvor gemeldeter Einheiten. Die Zuteilung ist ohne Kaufpreis und es wurden keine Insiderverkäufe gemeldet.

Positive
  • None.
Negative
  • None.

Orthofix Medical (NASDAQ:OFIX) ha presentato un Modulo 4 comunicando che la direttrice Vickie L. Capps ha ricevuto 18.841 unità azionarie differite il 18 giugno 2025. Queste unità maturano completamente un anno dopo la data di assegnazione, a condizione che prosegua il servizio nel consiglio, e si convertiranno in azioni ordinarie entro 45 giorni dalla sua separazione dall’azienda. Dopo l’assegnazione, la proprietà beneficiaria di Capps è aumentata a 21.934 azioni, incluse 3.093 unità precedentemente comunicate. L’assegnazione non prevede alcun prezzo d’acquisto e non sono state segnalate vendite da parte degli insider.

Orthofix Medical (NASDAQ:OFIX) presentó un Formulario 4 revelando que la directora Vickie L. Capps recibió 18,841 unidades de acciones diferidas el 18 de junio de 2025. Estas unidades se consolidan en su totalidad un año después de la fecha de concesión, condicionado a la continuidad en el consejo, y se convertirán en acciones comunes dentro de los 45 días posteriores a su separación de la empresa. Tras la adjudicación, la propiedad beneficiaria reportada de Capps aumentó a 21,934 acciones, que incluyen 3,093 unidades previamente divulgadas. La adjudicación no tiene precio de compra y no se reportaron ventas internas.

Orthofix Medical (NASDAQ:OFIX)는 이사 Vickie L. Capps가 2025년 6월 18일에 18,841개의 이연 주식 단위를 부여받았음을 공개하는 Form 4를 제출했습니다. 이 단위들은 부여일로부터 1년 후에 전액 취득되며, 계속 이사회에 재직하는 조건이 붙어 있습니다. 또한, 회사와의 분리 후 45일 이내에 보통주로 전환됩니다. 이번 수여로 인해 Capps의 보고된 실질 소유 주식 수는 21,934주로 증가했으며, 여기에는 이전에 공개된 3,093 단위가 포함되어 있습니다. 이번 수여는 구매 가격이 없으며, 내부자 매도는 보고되지 않았습니다.

Orthofix Medical (NASDAQ:OFIX) a déposé un formulaire 4 révélant que la directrice Vickie L. Capps s’est vu attribuer 18 841 unités d’actions différées le 18 juin 2025. Ces unités seront entièrement acquises un an après la date d’attribution, sous réserve de la poursuite de son mandat au conseil, et seront converties en actions ordinaires dans les 45 jours suivant son départ de l’entreprise. Suite à cette attribution, la propriété bénéficiaire déclarée de Capps est passée à 21 934 actions, incluant 3 093 unités déjà divulguées auparavant. Cette attribution ne comporte aucun prix d’achat et aucune vente d’initiés n’a été signalée.

Orthofix Medical (NASDAQ:OFIX) hat ein Formular 4 eingereicht, in dem offengelegt wird, dass die Direktorin Vickie L. Capps am 18. Juni 2025 18.841 aufgeschobene Aktienanteile erhalten hat. Diese Anteile werden ein Jahr nach dem Gewährungsdatum vollständig erworben, vorausgesetzt, sie bleibt im Vorstand tätig, und werden innerhalb von 45 Tagen nach ihrem Ausscheiden aus dem Unternehmen in Stammaktien umgewandelt. Nach der Zuteilung erhöhte sich Capps’ gemeldetes wirtschaftliches Eigentum auf 21.934 Aktien, einschließlich 3.093 zuvor gemeldeter Einheiten. Die Zuteilung ist ohne Kaufpreis und es wurden keine Insiderverkäufe gemeldet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CAPPS VICKIE L

(Last) (First) (Middle)
3451 PLANO PARKWAY

(Street)
LEWISVILLE 75056

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [ OFIX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/18/2025 A 18,841(1) A $0 21,934(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
2. Includes 3,093 previously reported deferred stock units.
/s/ J. Andres Cedron, attorney-in-fact 06/23/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did Orthofix director Vickie L. Capps acquire in the June 18 2025 transaction?

The Form 4 reports an award of 18,841 deferred stock units, each convertible into one share of Orthofix common stock.

What is Vickie L. Capps’ total beneficial ownership in OFIX after this award?

After the grant, she beneficially owns 21,934 shares (including previously reported units).
Orthofix Med Inc

NASDAQ:OFIX

OFIX Rankings

OFIX Latest News

OFIX Latest SEC Filings

OFIX Stock Data

573.85M
38.53M
2.76%
91.88%
6.12%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
LEWISVILLE